The present invention relates to the use of ellagic acid for the treatment of gastrointestinal disorders by stimulating the motility of the GI tract. In particular the present invention relates to a method of treatment of constipation, heartburn, non ulcer dyspepsia, GERD, and/or esophagitis, with a pharmaceutical composition comprising a safe and effective amount of ellagic acid or pharmaceutically acceptable salts or esters thereof. Preferably the ellagic acid is administered perorally.
A pharmaceutical composition comprising an effective amount of an extract or lyophilized extract or at least one bioactive fraction obtained from the plant Woodfordia fruticosa along with one or more pharmaceutically acceptable additives/carriers for treating ulcer caused by the conditions such as stress induced ulcer, peptic ulcer, cold restraint induced ulcer, drug induced ulcer and acid induced ulcer, also used as specific inhibitor of gastric H.sup.+, K.sup.+-ATPase and anti-Helicobacter pylori activity.
The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B, may be purified from natural sources, such as plant material (e.g. Epilobium angustifolium).
A composition extracted from nut husks including a method of forming the composition, where the composition is useful in healing wounds. The method includes collecting pecan husks, pressing the pecan husks thereby expressing fluid from the husks, and collecting the expressed fluid. The extraction process is conducted in an inert environment thereby preventing oxidation of the expressed fluid. After collection, the expressed fluid can be transferred to storage prior to use, such as in foil packets or glass tubes.
The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a cell adhesion promoter.
A method of obtaining a pathogen shield from nut husks where the composition is useful in promoting the wound healing. The method includes collecting nut husks, extracting fluid resident in the husks, and storing the collected fluid. The extraction process is conducted in an inert environment thereby preventing oxidation of the fluid. After collection, the expressed fluid can be transferred to storage prior to use, such as in metal-foil packets or glass ampoules.
